Look for New GLP-1 Agonists for Type 2 Diabetes

February 2018

You'll see Adlyxine (ad-LIKS-een, lixisenatide) and Ozempic (oh-ZEM-pik, semaglutide) join the crowded field of GLP-1 agonists.

Adlyxine is available now...and Ozempic will be in March. This will bring the tally in Canada to six GLP-1 agonist products for diabetes.

Be familiar with how the different agents compare.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Diabetes Look for New GLP-1 Agonists for Type 2 Diabetes
Monitoring Compare FreeStyle Libre and Other Continuous Glucose Monitors
Women's Health Ease Fears About Breast Cancer Risk With Hormonal Contraception
Natural Health Products Be Aware That Biotin May Skew Lab Test Results
Natural Health Products Watch for Warnings of Liver Damage on Labels of Green Tea Extract Products
Cardiology Use "ABCDs" to Optimize Meds for Stable Coronary Artery Disease
Asthma Ensure Long-Acting Beta-Agonists Aren't Used Alone for Asthma
Travel Medicine Share Strategies to Limit Altitude Sickness
Psoriasis Know Key Points About Biologics for Your Patients With Psoriasis
Nausea & Vomiting Consider Akynzeo for Highly Emetogenic Chemotherapy
Practice Get Tools to Tackle This Flu Season
Practice Advise Patients That Using Expired EpiPen May Be Needed During the Shortage